Abstract:Introduction: Severe pneumonia is a crucial issue in the development of acute kidney injury (AKI). This study evaluated the efficacy of early goal-directed renal replacement therapy (GDRRT) for the treatment of severe pneumonia-associated AKI. Methods: In this real-world retrospective cohort study, we recruited 180 patients with severe pneumonia who were hospitalized and received GDRRT in a third-class general hospital in East China between January 1, 2017, and December 31, 2021. Clinical data on baseline characteristics, biochemical indicators, and renal replacement therapy were collected. Patients were divided into Early and Late RRT groups according to fluid status, inflammation progression, and pulmonary radiology. We investigated in-hospital all-cause mortality (primary endpoint) and renal recovery (secondary endpoint) between the two groups. Results: Among the 154 recruited patients, 80 and 74 were in the early and late RRT groups, respectively. There were no significant differences in the demographic characteristics between the two groups. The duration of admission to RRT initiation was significantly shorter in Early RRT group [2.5(1.0, 8.7) d vs. 5.0(1.5,13.5) d, p = 0.027]. At RRT initiation, the patients in the Early RRT group displayed a lower percentage of fluid overload, lower doses of vasoactive agents, higher CRP levels, and higher rates of radiographic progression than those in the Late RRT group. The all-cause in-hospital mortality was significantly lower in the Early RRT group than in Late group (52.5% vs. 86.5%, p < 0.001). Patients in the Early RRT group displayed a significantly higher proportion of complete renal recovery at discharge (40.0% vs. 8.1%, p < 0.001). Conclusion: This study clarified that early GDRRT for the treatment of severe pneumonia-associated AKI based on fluid status and inflammation progression, was associated with reduced hospital mortality and better recovery of renal function. Our preliminary study suggests that early initiation of RRT may be an effective approach for severe pneumonia-associated AKI.

An Evidence-Based Interdisciplinary Protocol for Renal Transplant Recipients with Severe Pneumonia: A 4-Year Accumulated Experience.

Early- And Late-Onset Severe Pneumonia After Renal Transplantation

Analysis of Eleven Cases of Severe Pneumonia in Kidney Transplant Recipients

Pharmaceutical Care of Pulmonary Infection After Renal Transplantation

Comparison of Two Protocols for the Treatment of Severe Pneumonia after Renal Transplantation

An aggressive systematic strategy for acute respiratory distress syndrome caused by severe pneumonia after renal transplantation.

A clinical analysis of post-renal transplant pulmonary infection

Management of Patients with Severe Pulmonary Infection after Renal Transplantation

THE DIAGNOSIS AND TREATMENT OF SEVERE PNEUMONIA IN KIDNEY TRANSPLANT RECIPIENTS

Pneumonia incidence in renal transplantation: Factors associated with declining rates

Pneumonia secondary to immunosuppressant regimens in renal transplant patients:a retrospective analysis of 51 cases

Clinical descriptive analysis of severe Pneumocystis jirovecii pneumonia in renal transplantation recipients

Causes and Treatments of Severe Pulmonary Infection in Kidney Transplant Recipients

2117. Outcomes and Risk Factors Associated with Development of Pneumonia in Lung Transplant Recipients in the Year After Transplant

Diagnosis and treatment of Pneumocystis jirovecii pneumonia after renal transplantation: a report of 20 cases

Hospital-Acquired and Ventilator-Associated Pneumonia Early After Lung Transplantation: A Prospective Study on Incidence, Pathogen Origin, and Outcome

Early goal-directed renal replacement therapy in severe pneumonia associated acute kidney injury

[Evaluation of Mechanical Ventilation for Patients with Acute Respiratory Distress Syndrome As a Result of Interstitial Pneumonia after Renal Transplantation].

Clinical Analysis of 2520 Renal Transplantations in One Center

Clinical Analysis of Death Risk Factors in Pneumonia after Renal Transplantation

Moderate-dose glucocorticoids as salvage therapy for severe pneumonia in renal transplant recipients: a single-center feasibility study